Terms: = Breast cancer AND KDM5A, RBBP2, 5927, JARID1A, ENSG00000073614
22 results:
1. Comprehensive profiling of pathogenic germline large genomic rearrangements in a pan-cancer analysis.
Sun Z; Bai C; Su M; Tang H; Wu X; Wang Y; Bao H; Liu X; Wu X; Shao Y; Xu B
Mol Oncol; 2023 Sep; 17(9):1917-1929. PubMed ID: 37013911
[TBL] [Abstract] [Full Text] [Related]
2. Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor-positive breast cancer.
Jones RB; Farhi J; Adams M; Parwani KK; Cooper GW; Zecevic M; Lee RS; Hong AL; Spangle JM
Cancer Res Commun; 2022 Dec; 2(12):1569-1578. PubMed ID: 36970726
[TBL] [Abstract] [Full Text] [Related]
3. Fbxo22 inhibits metastasis in triple-negative breast cancer through ubiquitin modification of kdm5a and regulation of H3K4me3 demethylation.
Li S; He J; Liao X; He Y; Chen R; Chen J; Hu S; Sun J
Cell Biol Toxicol; 2023 Aug; 39(4):1641-1655. PubMed ID: 36112263
[TBL] [Abstract] [Full Text] [Related]
4. Expression and prognostic values of ARID family members in breast cancer.
Zhang J; Hou S; You Z; Li G; Xu S; Li X; Zhang X; Lei B; Pang D
Aging (Albany NY); 2021 Feb; 13(4):5621-5637. PubMed ID: 33592583
[TBL] [Abstract] [Full Text] [Related]
5. Extended Recognition of the Histone H3 Tail by Histone Demethylase kdm5a.
Petronikolou N; Longbotham JE; Fujimori DG
Biochemistry; 2020 Feb; 59(5):647-651. PubMed ID: 31985200
[TBL] [Abstract] [Full Text] [Related]
6. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
7. HER2-positive breast-cancer cell lines are sensitive to KDM5 inhibition: definition of a gene-expression model for the selection of sensitive cases.
Paroni G; Bolis M; Zanetti A; Ubezio P; Helin K; Staller P; Gerlach LO; Fratelli M; Neve RM; Terao M; Garattini E
Oncogene; 2019 Apr; 38(15):2675-2689. PubMed ID: 30538297
[TBL] [Abstract] [Full Text] [Related]
8. KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance.
Hinohara K; Wu HJ; Vigneau S; McDonald TO; Igarashi KJ; Yamamoto KN; Madsen T; Fassl A; Egri SB; Papanastasiou M; Ding L; Peluffo G; Cohen O; Kales SC; Lal-Nag M; Rai G; Maloney DJ; Jadhav A; Simeonov A; Wagle N; Brown M; Meissner A; Sicinski P; Jaffe JD; Jeselsohn R; Gimelbrant AA; Michor F; Polyak K
Cancer Cell; 2018 Dec; 34(6):939-953.e9. PubMed ID: 30472020
[TBL] [Abstract] [Full Text] [Related]
9. Genome-Wide Methylation Analysis Identifies NOX4 and kdm5a as Key Regulators in Inhibiting breast cancer Cell Proliferation by Ginsenoside Rg3.
Ham J; Lee S; Lee H; Jeong D; Park S; Kim SJ
Am J Chin Med; 2018; 46(6):1333-1355. PubMed ID: 30149757
[TBL] [Abstract] [Full Text] [Related]
10. ChIP-seq analysis reveals alteration of H3K4 trimethylation occupancy in cancer-related genes by cold atmospheric plasma.
Lee S; Park S; Lee H; Jeong D; Ham J; Choi EH; Kim SJ
Free Radic Biol Med; 2018 Oct; 126():133-141. PubMed ID: 30096431
[TBL] [Abstract] [Full Text] [Related]
11. Selective Inhibition of Lysine-Specific Demethylase 5A (kdm5a) Using a Rhodium(III) Complex for Triple-Negative breast cancer Therapy.
Yang GJ; Wang W; Mok SWF; Wu C; Law BYK; Miao XM; Wu KJ; Zhong HJ; Wong CY; Wong VKW; Ma DL; Leung CH
Angew Chem Int Ed Engl; 2018 Oct; 57(40):13091-13095. PubMed ID: 29968419
[TBL] [Abstract] [Full Text] [Related]
12. Structure-based design and discovery of potent and selective KDM5 inhibitors.
Nie Z; Shi L; Lai C; O'Connell SM; Xu J; Stansfield RK; Hosfield DJ; Veal JM; Stafford JA
Bioorg Med Chem Lett; 2018 May; 28(9):1490-1494. PubMed ID: 29627262
[TBL] [Abstract] [Full Text] [Related]
13. Probing the metabolic phenotype of breast cancer cells by multiple tracer stable isotope resolved metabolomics.
Lane AN; Tan J; Wang Y; Yan J; Higashi RM; Fan TW
Metab Eng; 2017 Sep; 43(Pt B):125-136. PubMed ID: 28163219
[TBL] [Abstract] [Full Text] [Related]
14. KDM5 lysine demethylases are involved in maintenance of 3'UTR length.
Blair LP; Liu Z; Labitigan RL; Wu L; Zheng D; Xia Z; Pearson EL; Nazeer FI; Cao J; Lang SM; Rines RJ; Mackintosh SG; Moore CL; Li W; Tian B; Tackett AJ; Yan Q
Sci Adv; 2016 Nov; 2(11):e1501662. PubMed ID: 28138513
[TBL] [Abstract] [Full Text] [Related]
15. Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance.
Gale M; Sayegh J; Cao J; Norcia M; Gareiss P; Hoyer D; Merkel JS; Yan Q
Oncotarget; 2016 Jun; 7(26):39931-39944. PubMed ID: 27224921
[TBL] [Abstract] [Full Text] [Related]
16. PI3K/AKT Signaling Regulates H3K4 Methylation in breast cancer.
Spangle JM; Dreijerink KM; Groner AC; Cheng H; Ohlson CE; Reyes J; Lin CY; Bradner J; Zhao JJ; Roberts TM; Brown M
Cell Rep; 2016 Jun; 15(12):2692-704. PubMed ID: 27292631
[TBL] [Abstract] [Full Text] [Related]
17. Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.
Varier RA; Carrillo de Santa Pau E; van der Groep P; Lindeboom RG; Matarese F; Mensinga A; Smits AH; Edupuganti RR; Baltissen MP; Jansen PW; Ter Hoeve N; van Weely DR; Poser I; van Diest PJ; Stunnenberg HG; Vermeulen M
J Biol Chem; 2016 Apr; 291(14):7313-24. PubMed ID: 26841866
[TBL] [Abstract] [Full Text] [Related]
18. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases.
Horton JR; Engstrom A; Zoeller EL; Liu X; Shanks JR; Zhang X; Johns MA; Vertino PM; Fu H; Cheng X
J Biol Chem; 2016 Feb; 291(6):2631-46. PubMed ID: 26645689
[TBL] [Abstract] [Full Text] [Related]
19. Functional proteomics of the epigenetic regulators ASXL1, ASXL2 and ASXL3: a convergence of proteomics and epigenetics for translational medicine.
Katoh M
Expert Rev Proteomics; 2015 Jun; 12(3):317-28. PubMed ID: 25835095
[TBL] [Abstract] [Full Text] [Related]
20. Histone lysine demethylases in breast cancer.
Paolicchi E; Crea F; Farrar WL; Green JE; Danesi R
Crit Rev Oncol Hematol; 2013 May; 86(2):97-103. PubMed ID: 23266085
[TBL] [Abstract] [Full Text] [Related]
[Next]
